NHS England updates CDF List
NHS England updates CDF List
NHS England has updated the Cancer Drugs Fund List. The latest version (v1.352) was uploaded to the NHS England Website on Monday 3, March 2025.
The following changes have been introduced:
Blinatumomab (BLI5)
Blinatumomab for treating ADULT patients in first morphological complete remission and without minimal residual disease after 1st line intensive induction and intensification chemotherapy for Philadelphia chromosome negative B-cell precursor acute lymphoblastic leukaemia where the following criteria have been met
Treatment criteria added
Blinatumomab (BLI3)
The treatment of patients in first complete haematological complete remission and with minimal residual disease post 1st line induction chemotherapy in B-precursor acute lymphoblastic leukaemia in ADULT patients where all the following criteria are met:
Treatment criterion (#6) updated